Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
Forget CSL shares, Cochlear Ltd (ASX: COH), Nanosonics Ltd (ASX:NAN) and ResMed Inc (ASX:RMD) shares are amongst my top three ASX healthcare shares.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.26% at lunch.
Cochlear Limited (ASX:COH) has announced the launch of a new implant this morning. What does this mean to the business?
Australia’s population is ageing and companies like Cochlear Limited (ASX: COH) and CSL Limited (ASX: CSL) could stand to benefit.
With the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO) down 1% some investors might be asking ‘what on earth has happened to OncoSil Medical Ltd (ASX: OSL)’?
Cochlear Ltd (ASX:COH) is often referred to as one of the best health care companies in the world. It has truly been life changing for me.
Nanosonics Ltd (ASX:NAN) and CSL Ltd (ASX:CSL) shares could keep beating the S&P/ASX 200 (INDEXASX:XJO) index.
Cochlear Limited (ASX:COH) shares are down 7.7% after reporting its half year result to December 2018.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.30% at lunch.
